Monday, November 17, 2014

Juno Therapeutics Files For IPO

Seattle-based Juno Therapeutics filed for an IPO this morning, saying that it is looking to raise up to $150M on the NASDAQ Global Market as JUNO. Juno's IPO is being underwritten by Morgan Stanley, J.P. Morgan, Goldman, Sachs & Co., and Leerink Partners. Juno is backed by ARCH Ventures, CL Alaska; JT Line Partners; and Fred Hutchinson Cancer Research Center. Juno Therapeutics is developing cancer immunotherapies.